Mark Scapens
Director/Board Member at CANNASOUTH LIMITED
Profile
Mark Scapens is a professional who currently holds two positions as a Non-Executive Director at Cannasouth Ltd.
and as a Director at Eqalis Pharmaceuticals Ltd.
He previously worked as a Non-Executive Director at Aspire2 Group Ltd.
Mark Scapens active positions
| Companies | Position | Start |
|---|---|---|
| CANNASOUTH LIMITED | Director/Board Member | - |
Eqalis Pharmaceuticals Ltd
 Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Director/Board Member | - |
Former positions of Mark Scapens
| Companies | Position | End |
|---|---|---|
Aspire2 Group Ltd.
 Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CANNASOUTH LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Aspire2 Group Ltd.
Aspire2 Group Ltd. Miscellaneous Commercial ServicesCommercial Services Aspire2 Group Ltd. provide education and vocational training to domestic, international and business to business students. The firm offers private tertiary education and professional and vocational training. The company is headquartered in Auckland, New Zealand. | Commercial Services |
Eqalis Pharmaceuticals Ltd
Eqalis Pharmaceuticals Ltd Pharmaceuticals: MajorHealth Technology Part of Cannasouth Ltd., Eqalis Pharmaceuticals Ltd is a New Zealander company that manufactures cannabis-based pharmaceuticals. The company is based in Katikati, New Zealand. The CEO of the company is Greg Misson. Eqalis Pharmaceuticals was acquired by Cannasouth Ltd. on May 24, 2023 for $27.30 million. | Health Technology |
- Stock Market
- Insiders
- Mark Scapens
